# Aging-Induced QT Prolongation as a Potential Contributor to Longevity

**Authors:** Simon W. Rabkin

PMC · DOI: 10.3390/jcdd13020086 · 2026-02-09

## TL;DR

This paper explores how aging-related changes in heart electrical activity, like prolonged QT intervals, might contribute to shorter lifespans.

## Contribution

It proposes that QT interval prolongation in aging could be a marker or contributor to reduced human longevity.

## Key findings

- QT interval increases with age and is linked to sudden cardiac death.
- Conditions like dementia and Parkinson’s disease are associated with prolonged QT intervals and sudden death.
- Aging processes may alter heart repolarization through changes in ion channels and heart composition.

## Abstract

The objective of this paper was to review the possibility that the QT interval may be a marker of adult human longevity or life expectancy. Following a literature review, data supporting this possibility was assembled and consists of the following. First, in adults, QT interval increases with increasing age. This is analogous to aging-induced hypertension and diabetes mellitus, both of which are associated with shorter longevity. Second, older persons frequently die suddenly regardless of whether or not they have chronic illnesses for which death is expected. Third, longer QTintervals are associated with increased probability of sudden death. Fourth, patients with two conditions associated with accelerated brain aging, namely dementia and Parkinson’s disease, show longer QTcs than age-matched controls. Both of these conditions are associated with sudden cardiac death. Fifth, aging processes may affect the molecular determinants of the QT interval, alter heart composition with increased myocardial fibrosis, or alter the amount of sympathetic and parasympathetic tone, any or all of which can alter myocardial repolarization and the duration of the QTc. Sixth, considering the molecular determinants of the QT interval in the aging heart, which has longer transmembrane action potentials, several factors can account for this change, including changes in late inward Na+ current (INaL), IKr, Ica, Ito, and KATP channels. Transgenic mice overexpressing the Kir6.1 subunit of a KATP channel show a prolonged QT interval and reduced longevity, with animals appearing to die suddenly. Seventh, chronic kidney disease, which is associated with a reduced lifespan, is associated with reduced expression of the anti-aging factor Klotho and Klotho-deficient mice have a prolonged QTc and a reduced lifespan. Taken together, there is a cogent case for factors that increase action potential duration in the aging heart, as recognized by increased QTc, to act in concert with other factors to produce fatal arrhythmias leading to sudden cardiac death and shortened longevity.

## Linked entities

- **Genes:** CG9701 (uncharacterized protein) [NCBI Gene 39872], KCNJ8 (potassium inwardly rectifying channel subfamily J member 8) [NCBI Gene 3764]
- **Diseases:** dementia (MONDO:0001627), Parkinson’s disease (MONDO:0005180), chronic kidney disease (MONDO:0005300)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** KL (klotho) [NCBI Gene 9365] {aka HFTC3, KLA}, KCNJ8 (potassium inwardly rectifying channel subfamily J member 8) [NCBI Gene 3764] {aka KIR6.1, uKATP-1}, Calmodulin [NCBI Gene 100724214], IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, Kcnh2 (potassium voltage-gated channel, subfamily H (eag-related), member 2) [NCBI Gene 16511] {aka ERG1, LQT, Lqt2, M-erg, Merg1, merg1a}, KCNQ1 (potassium voltage-gated channel subfamily Q member 1) [NCBI Gene 3784] {aka ATFB1, ATFB3, JLNS1, KCNA8, KCNA9, KVLQT1}, RYR2 (ryanodine receptor 2) [NCBI Gene 6262] {aka ARVC2, ARVD2, RYR-2, RyR, VACRDS, VTSIP}, KCNH2 (potassium voltage-gated channel subfamily H member 2) [NCBI Gene 3757] {aka ERG-1, ERG1, H-ERG, HERG, HERG1, Kv11.1}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, Kcnj8 (potassium inwardly-rectifying channel, subfamily J, member 8) [NCBI Gene 16523] {aka Kir6.1, gnite, slmbr, sltr, uKATP-1}, TRPM7 (transient receptor potential cation channel subfamily M member 7) [NCBI Gene 54822] {aka ALSPDC, CHAK, CHAK1, LTRPC7, LTrpC-7, TRP-PLIK}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, Scn5a (sodium channel, voltage-gated, type V, alpha) [NCBI Gene 20271] {aka Nav1.5, Nav1.5c, SkM1, SkM2, mH1}, Fgf23 (fibroblast growth factor 23) [NCBI Gene 64654] {aka Fgf8b}, Inhca (inhibitor of carbonic anhydrase) [NCBI Gene 71775] {aka 1300017J02Rik, Ica, mICA}, Kl (klotho) [NCBI Gene 16591] {aka alpha-kl}
- **Diseases:** myocardial ischemia (MESH:D017202), Ventricular ectopy (MESH:D050030), Sudden death (MESH:D003645), myocardial infarction (MESH:D009203), drug toxicity (MESH:D064420), reperfusion injury (MESH:D015427), atherosclerotic cardiovascular disease (MESH:D050197), Action (MESH:D009207), Cardiac Death (MESH:D003643), Hypertension (MESH:D006973), QT interval prolongation (MESH:D008133), ventricular tachycardia (MESH:D017180), ventricular fibrillation (MESH:D014693), pulmonary hypertension (MESH:D006976), cognitive decline (MESH:D003072), kidney diseases (MESH:D007674), heart failure (MESH:D006333), Torsade de Pointe (MESH:D016171), cardiac disease (MESH:D006331), dementia (MESH:D003704), QT dispersion (MESH:C563184), in QT interval (OMIM:610141), cardiac hypertrophy (MESH:D006332), weakness (MESH:D018908), diabetes mellitus (MESH:D003920), electrolyte abnormalities (MESH:D014883), Chronic kidney disease (MESH:D051436), asystole (MESH:D006323), cardiomyocyte loss (MESH:D016388), Cardiac fibrosis (MESH:D005355), uremia (MESH:D014511), inflammatory (MESH:D007249), injury to (MESH:D014947), coronary heart disease (MESH:D003327), Parkinson disease (MESH:D010300), myocardial remodeling (MESH:D064752), genetic abnormalities (MESH:D030342), premature ventricular complexes (MESH:D018879), ischemia (MESH:D007511), frailty (MESH:D000073496), arrhythmia (MESH:D001145), pneumonia (MESH:D011014), Cardiac Sudden Death (MESH:D016757), stroke (MESH:D020521), heart block (MESH:D006327), wasting (MESH:D019282)
- **Chemicals:** catecholamine (MESH:D002395), hydrogen peroxide (MESH:D006861), Ca2+ (-), Na+ (MESH:D012964), doxorubicin (MESH:D004317), reactive oxygen species (MESH:D017382), calcium (MESH:D002118), glucose (MESH:D005947), ATP (MESH:D000255), isoproterenol (MESH:D007545), ranolazine (MESH:D000069458), atenolol (MESH:D001262), Losartan (MESH:D019808), oxygen (MESH:D010100), Testosterone (MESH:D013739)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606], Cavia porcellus (domestic guinea pig, species) [taxon 10141], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** S422L

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12942042/full.md

---
Source: https://tomesphere.com/paper/PMC12942042